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Abstract
The human DNA mismatch repair (MMR) process is crucial to maintain the integrity of the genome and requires many
different proteins which interact perfectly and coordinated. Germline mutations in MMR genes are responsible for the
development of the hereditary form of colorectal cancer called Lynch syndrome. Various mutations mainly in two MMR
proteins, MLH1 and MSH2, have been identified so far, whereas 55% are detected within MLH1, the essential component of
the heterodimer MutLa (MLH1 and PMS2). Most of those MLH1 variants are pathogenic but the relevance of missense
mutations often remains unclear. Many different recombinant systems are applied to filter out disease-associated proteins
whereby fluorescent tagged proteins are frequently used. However, dye labeling might have deleterious effects on MutLa’s
functionality. Therefore, we analyzed the consequences of N- and C-terminal fluorescent labeling on expression level,
cellular localization and MMR activity of MutLa. Besides significant influence of GFP- or Red-fusion on protein expression we
detected incorrect shuttling of single expressed C-terminal GFP-tagged PMS2 into the nucleus and found that C-terminal
dye labeling impaired MMR function of MutLa. In contrast, N-terminal tagged MutLas retained correct functionality and can
be recommended both for the analysis of cellular localization and MMR efficiency.
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Introduction
DNA mismatch repair (MMR) is responsible for the correction
of DNA replications errors and therefore essential for maintaining
genomic stability and preventing tumor formation. Germline
mutations in any of four MMR genes (MLH1, MSH2, MSH6,
PMS2) cause the development of Lynch syndrome. MMR
deficiency in tumors of patients with Lynch syndrome is
characterized by microsatellite instability (MSI), which can be
detected in more than 95% of associated carcinoma [1].
The initial step of human MMR is the recognition of mismatches
by the heterodimer MutSa (MSH2 and MHS6) or MutSb (MSH2
and MSH3). In the subsequent step the MutS complex recruits a
MutL complex, most dominantly MutLa (MLH1 and PMS2) of
which MLH1 is the essential component stabilizing its dimeric
partner protein PMS2. Especially the last C-terminal alpha helix of
MLH1 seems to be most important for PMS2 stabilization but also
for the correction of mispairs as well as for checkpoint signaling in
response e.g. to 6-thioguanine [2]. Beside this, MutLa is responsible
for the recruitment of many downstream proteins essential for the
repair process. Moreover, several different MMR dependent but
also independent proteins have been published to interact with
MutLa [3,4,5,6,7], suggesting its involvement in several other
cellular processes like apoptosis and protein transport. Therefore,
binding capacities as well as accessibility of MutLa’s surface are
supposed to be of utmost importance for the functional involvement
of MutLa in these different processes.
Many in vitro data have been published using N-terminal
[8,9,10,11] or C-terminal [12,13,14,15,16,17] fluorescent tagged
MMR proteins. However, fluorescent labeling might have
significant influence on the functionality of tagged proteins
[18,19,20].
Therefore, we investigated the influence of N- or C-terminal
dye labeling of MutLa on expression level, cellular localization
and repair function. Using different combinations of coexpressed
GFP- and Red-labeled or unlabeled MLH1 and PMS2 proteins,
we compared expression level, cellular localization and the MMR
functionality of these MutLa variants with the untagged MutLa.
Results
Single expression of MLH1 or PMS2 is significantly
influenced by fluorescent labeling
In order to determine the influence of fluorescent labeling on
single expressed MLH1 and PMS2 variants each of these proteins
was transfected and expressed in HEK293T cells.
As shown in Figure 1A, MLH1 is well expressed without
coexpression of PMS2. However, N-terminal GFP (Figure 1A,
lane 3) and C-terminal Red labeling (Figure 1A, lane 4) led to
decreased expression levels.
In contrast, PMS2 (Figure 1B), normally unstable without
coexpressed heterodimeric partner protein MLH1 [2,22] and hardly
expressed despite using overexpression-plasmid pcDNA3.1
(Figure 1B, lane 6), is well expressed and stable with N-terminal
GFP or Red fluorescent labeling (Figure 1B, lane 7+9). However, C-
terminal GFP or Red labeling resulted in very low or nearly
undetectable expression of PMS2(Figure 1B, lane 8+10),respectively.
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The influence of dye labeling on MutLa expression rate was
analyzed by quantification of MLH1 and PMS2 levels 48 h after
transiently cotransfection of different variants.
As shown in Figure 2, expression of fluorescent tagged-MutLa
variants (Figure 2, lane 3–18) significantly differs from the
untagged MutLa control (Figure 2, lane 2).
MLH1 expression in all single PMS2 labeled MutLas (Figure 2,
lane 3–6), in single MLH1 tagged (MLH1-GFP-N (Figure 2, lane
7) or MLH1-GFP-C (Figure 2, lane 8)) as well as in the double dye
labeled MutLa variants, MLH1-GFP-C/PMS2-Red-C (Figure 2,
lane 14) or MLH1-Red-C/PMS2-GFP-N (Figure 2, lane 17), was
around 40–60% decreased compared to the untagged control. In
contrast, expression of MLH1-GFP-N coexpressed with different
Red labeled PMS2 (Figure 2, lane 11+12) was significantly higher
in comparison to the control.
MLH1 expression of all other MutLa variants was about 70–
80% compared to the control.
Looking at PMS2 expression, completely different results were
detectable. Irrespective of whether MLH1 was tagged or not, C-
terminal labeling of PMS2 with Red (PMS2-Red-C (Figure 2, lane
6, 12, 14)) led to dramatically decreased expression levels of
around only 10% compared to untagged PMS2.
However, .100% of wild-type PMS2 expression was detectable
when unlabeled PMS2 was coexpressed with MLH1-GFP-C
(Figure 2, lane 8) or N-terminal labeled PMS2-GFP-N was
coexpressed with MLH1-Red-N (Figure 2, lane 15).
In all other tested MutLa variants PMS2 expression was on
average 30–60% compared to unlabeled PMS2.
Subcellular localization of dye tagged MutLa
In order to analyze the influence of fluorescent proteins (GFP as
well as Red) on subcellular protein localization, single expressed
MLH1 or PMS2 as well as different coexpressed MutLa variants
were analyzed in comparison to unlabeled MutLa using confocal
laser microscopy.
As shown in Figure 3, dye tagged single transfected MLH1 was,
regardless of the orientation of the fluorescent tag, exclusively
localized in the nucleus.
In contrast PMS2-GFP-N, PMS2-Red-C as well as PMS2-Red-
N were, if transfected without heterodimeric partner protein
MLH1, only detectable in the cytoplasm of transfected cells.
However, single transfection of the PMS2-GFP-C variant led to
strong nuclear localization of PMS2 in HEK293T cells.
All cotransfected MutLa variants were detected most domi-
nantly in the nucleus (data not shown).
MMR function is significantly impaired by fluorescent
tags
MMR function of Lynch syndrome variants is commonly tested
by in vitro MMR-assays [16,28,29]. Beside untagged, also dye-
labeled proteins are used to analyze not only MMR functionality
Figure 1. Dye tags influence single expression of MLH1 and
PMS2. To determine the influence of fluorescent tags on single
expressed MLH1 or PMS2 variants, HEK293T cells were transfected with
different (A) MLH1 or (B) PMS2 constructs. Amounts of expressed
proteins were assessed after Western blotting by measuring the signal
intensities of protein bands with Multi Gauge V3.2 software. Graphs
indicate the results (mean 6S.D.) of at least four independent
experiments in which the proportion of protein expression using an
unbiased method were presented. 1: MLH1 unlabeled; 2: MLH1-GFP-N;
3: MLH1-GFP-C; 4: MLH1-Red-N; 5: MLH1-Red-C; 6: PMS2 unlabeled; 7:
PMS2-GFP-N; 8: PMS2-GFP-C; 9: PMS2-Red-N; 10: PMS2-Red-C.
doi:10.1371/journal.pone.0031863.g001
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expression levels, HEK293T cells were transiently cotransfected with different MutLa constructs (see below) and (A) Western blot analysis was carried
out after 48 h using anti-MLH1 or anti-PMS2, respectively, controlled by b-actin detection. (B) Amounts of expressed proteins were assessed by
measuring the signal intensities of protein bands with Multi Gauge V3.2 software. Graphs indicate the results (mean 6S.D.) of at least four
independent experiments in which the proportion of protein expression using an unbiased method were presented. 1: negative control
(untransfected). 2: MLH1/PMS2 unlabeled; 3: MLH1/PMS2-GFP-N; 4: MLH1/PMS2-GFP-C; 5: MLH1/PMS2-Red-N; 6: MLH1/PMS2-Red-C; 7: MLH1-GFP-N/
PMS2; 8: MLH1-GFP-C/PMS2; 9: MLH1-Red-N/PMS2; 10: MLH1-Red-C/PMS2; 11: MLH1-GFP-N/PMS2-Red-N; 12: MLH1-GFP-N/PMS2-Red-C; 13: MLH1-
GFP-C/PMS2-Red-N; 14: MLH1-GFP-C/PMS2-Red-C; 15: MLH1-Red-N/PMS2-GFP-N; 16: MLH1-Red-N/PMS2-GFP-C; 17: MLH1-Red-C/PMS2-GFP-N; 18:
MLH1-Red-C/PMS2-GFP-C. Symbols see Figure 1.
doi:10.1371/journal.pone.0031863.g002
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interaction in parallel [10,17]. Hereby, several different MMR-
fusion-proteins were utilized carrying e.g. either N- or C-terminal
dye tags.
A dye-dependent change of protein function cannot be excluded
especially for C-terminal protein labeling since the very sensitive
MLH1/PMS2 interaction zone as well as the endonuclease
function are located at the C-terminus and of great importance
for the MMR function of MutLa [28]. Therefore, we determined
the influence of the fluorescent tag orientation on the MMR
functionality of MutLa.
All single PMS2 tagged (N- or C-terminal) MutLas were still
MMR proficient showing 80% or more MMR activity (Figure 4,
lane 3–6).
In contrast, most single MLH1 labeled (with the exception of
MLH1-GFP-N (Figure 4, lane 7) and most double fluorescent
labeled MutLa-variants showed less than 50% MMR activity
compared to wild-type MutLa. Hereby, MLH1-GFP-C coupled
with PMS2-Red-C or PMS2-Red-N, respectively showed the most
limited functionality. C-terminal GFP or N- and C-terminal Red
MLH1 labeling with or without combination of fluorescent labeled
PMS2 showed only #50% repair activity thus were MMR
deficient.
In contrast, dye tagged MutLa, consisting of N-terminal tagged
MLH1 and N-terminal fused PMS2 showed most MMR
functionality whereby MLH1-GFP-N/PMS2-Red-N showed 70–
85% MMR activity and therefore seems to be the most useful dye
tagged MutLa variant.
Discussion
Functional testing of MMR protein variants is of great
importance to distinguish pathogenetic relevant mutations and
non-pathogenetic polymorphisms detected in Lynch syndrome
families [16,30,31]. Beside repair activity, also cellular localization
and protein stability serve for the classification and dye tagged
variants are frequently used to simplify MMR-protein analysis
[2,8,16,30]. However, a negative impact of fluorescent labeling on
proteins’ functionality might be present [18,19,20]. Therefore, we
compared expression level, cellular localization and MMR activity
of untagged and dye tagged MutLa variants and found significant
changes in all parameters.
Expression levels of fluorescent labeled MutLas significantly
differ from unlabeled MutLa. As shown by our results, fusion of
GFP and Red can dramatically affect protein stabilization. N-
terminal fusion of dyes e.g. lead to stabilization even of single
expressed PMS2 which is normally unstable without its heterodi-
meric partner. Our observation of this dye-dependent effect is in
accordance to previously published data describing the large list of
possible effects using fluorescent fusion proteins [32]. Thus,
fluorescent tagged proteins do not seem to be useful for protein
stability analysis.
However, differences in protein expression seemed to be
without significant impact on MMR functionality of the
heterodimer. Weak protein-expression, e.g. of tagged PMS2, did
not automatically cause dramatic MMR decrease or vice versa,
which is in accordance to Cejka et al. who detected that the
amount of overexpressed MutLa is not the limiting factor in the
MMR assay so that protein expression could be strongly reduced
without functional impact [33].
Looking at the influence of dye labeling on MMR in detail, dye
tags generally decrease repair function of MutLa even if only one
partner protein was labeled. Hereby, labeling of MLH1 had a
stronger restrictive effect than PMS2 tagging which illustrates the
Figure 3. Subcellular localization of single expressed MLH1 and
PMS2 variants. HEK293T cells were transfected with different MLH1 or
PMS2 constructs as indicated to the left. MLH1 and PMS2 were visualized
after 48 h using confocal laser microscopy. Nuclei were counterstained
with TO-PRO-3 (middle column) after fixation and resulting overlay is
shown in the right column. As a control, unlabeled MLH1 or PMS2 was
transfected in parallel and visualized after 48 h using FITC-labeled goat
anti-mouse IgG Alexa Fluor 488 for MLH1 detection (shown in green; left
column) whereas unlabeled PMS2 was detected with the FITC-labeled
goat anti-rabbit IgG Alexa Fluor 555. All used labeled MLH1 and PMS2
constructs showed the same cellular localization as the unlabeled form,
with the exception of PMS2-GFP-C which was detected in the nucleus
although all other constructs were located in the cytoplasm.
doi:10.1371/journal.pone.0031863.g003
Fluorescent Tags Can Impair DNA Mismatch Repair
PLoS ONE | www.plosone.org 4 February 2012 | Volume 7 | Issue 2 | e31863well known great importance of MLH1 for MutLa stability,
transport and thereby MMR function [2,22,34].
Fluorescent tags fused to the C-terminus of MutLa components,
most obvious GFP-fusion to the C-terminus of MLH1 entirely
impair MMR function of the heterodimer. However, exclusively N-
terminal tagged MutLas showed MMR proficiency which empha-
sizes that the N-termini of MLH1 and PMS2 are much more
tolerant to dye protein extension than their C-termini. Since MutLa
was described to coordinate protein-protein interaction during the
MMR process via its N-terminus [35] the observed tolerance of this
domain to fluorescent dyes are explainable. In contrast, we assume
that C-terminal tags might lead to incorrect interaction of the
heterodimeric partners or to a strong hindrance of the MutLa
radius of action which would fit well to the great importance of the
last C-terminal alpha helix of MLH1 for nucleotide binding and
correction of mispairs [2]. Moreover, this postulation is enforced by
our computer modeling of a three-dimensional structure of dye
labeled MutLa (Figure 5) consisting of previously published
homologymodelsofMLH1andPMS2[24,25,26,27]and structures
of GFP or Red (PDB number: 2WSN (GFP); PDB number: 1G7K
(Red)). C-terminal interaction of MLH1 and PMS2 fix the C-
terminus of the heterodimeric complex and additional adhesion of
dye complexes might hide the functional surface and lead to the
observed impaired ability for MMR.
Although GFP and Red show only marginal differences in
structure,GFP overallhad lessimpact on MutLa function than Red.
Looking at the influence of fluorescent fusion on cellular protein
localization we found one dye-dependent incorrect protein
transport. While PMS2 is normally not able to enter the nucleus
without dimeric partner protein MLH1 [2,11,22,34] C-terminal
labeling with GFP (although PMS2-GFP-C was very weak
expressed) wrongly enables this protein to be shuttled into the
nucleus. This nuclear localization of single expressed C-terminal
dye tagged PMS2 was previously detected by Raevaara et al. as
well as Leong et al. who used a PMS2-GFP-C or a PMS2-Red-C
construct, respectively [13,15]. Leong and coworkers thereupon
postulated a weak nuclear import ability of PMS2. However, we
presume that nuclear import of C-terminal GFP tagged single
expressed PMS2 is only a dye-depending phenomenon and might
lead to an incorrect interpretation of mutational influence of
MLH1 on PMS2 transport mechanism.
In order to overcome the described problems, one might
consider switching the tags to any other of the numerous
fluorescent dyes available. However, due to high structural
similarities between all these dyes we do not expect relevant
functional differences compared to those generated with GFP or
Red. Impaired repair function of MutLa by C-terminal labeling
has to be assumed using any of these fluorescent dyes.
In summary, only fusion of fluorescent proteins to the N-termini
of MLH1 and PMS2 enable correct functionality and cellular
localization of MutLa and are recommended for testing of MutLa
variants without restrictions.
Materials and Methods
Cells and Cell Transfection
HEK293T cells, obtained from Dr. Kurt Ballmer (Paul Scherer
Institute, Villingen, Switzerland) were grown in Dulbecco’s
Modified Eagle Medium (DMEM) with 10% FCS. HEK293T is
a clone of HEK293 that expresses the SV40 large T antigen. As
previously published, MutLa is not expressed in HEK293T [21].
Transfection and cotransfection of HEK293T cells were carried
outasdescribed previously[7].Inbrief,HEK293T weretransfected
at 50–70% confluence with expression plasmids (1 mg/ml, respec-
tively) using 10 ml/ml of the cationic polymer polyethylenimine
(Polysciences, Warrington, PA; stock solution 1 mg/ml). 48 h post-
transfection whole cell extract was prepared for Western blot
analysis, MMR assay or confocal laser microscopy.
Plasmids
Used pcDNA3.1+/MLH1, pcDNA3.1+/PMS2, pECFP-C1/
MLH1 (MLH1-GFP-N) and pDSRed-C1/PMS2 (PMS2-Red-N)
Figure 4. Influence of fluorescent tags on MMR activity of MutLa. HEK293T cells were transiently cotransfected with various labeled or
unlabeld MutLa constructs and 48 h post transfection MMR activity of different MutLas were assessed in vitro in parallel with unlabeled MutLa by
quantifying the 39-nick-directed correction of a G-T mismatch in a restriction site of a plasmid substrate as detailed in ‘‘Materials and Methods’’ and as
previously described [10]. In vitro repair was scored on a 2-kb circular DNA substrate that contains an EcoRV site which is destroyed by a G-T
mismatch. Upon repair of the G-T mismatch to an A-T base pair the intact EcoRV site together with an AseI site gives rise to a 0.8- and a 1.2-kb
fragment, whereas unrepaired DNA is only linearized by AseI to a 2-kb fragment. Repair efficiency was assessed by measuring the signal intensities of
linearized and digested vector with Bio-Rad Quantity One software using the ‘‘rolling ball’’ baseline correction. The signal intensity of the repair bands
was divided by the intensity of all three bands. Repair efficiency of unlabeled MutLa was set at 100 percent and repair of fluorescent tagged MutLa
was determined in relation to the wild-type sample that was expressed, processed and tested in parallel. Average repair values and standard
deviations (6) were determined from four independent experiments. Single PMS2 tagged MutLas, single MLH1-GFP-N tagged MutLas as well as
MLH1-GFP-N coexpressed with PMS2-Red-N or MLH1-Red-N coexpressed with PMS2-GFP-N were MMR proficient while all other tagged variants
showed MMR deficiency. 1: mock control (untransfected). 2: MLH1/PMS2 unlabeled (positive control); 3: MLH1/PMS2-GFP-N; 4: MLH1/PMS2-GFP-C; 5:
MLH1/PMS2-Red-N; 6: MLH1/PMS2-Red-C; 7: MLH1-GFP-N/PMS2; 8: MLH1-GFP-C/PMS2; 9: MLH1-Red-N/PMS2; 10: MLH1-Red-C/PMS2; 11: MLH1-GFP-
N/PMS2-Red-N; 12: MLH1-GFP-N/PMS2-Red-C; 13: MLH1-GFP-C/PMS2-Red-N; 14: MLH1-GFP-C/PMS2-Red-C; 15: MLH1-Red-N/PMS2-GFP-N; 16: MLH1-
Red-N/PMS2-GFP-C; 17: MLH1-Red-C/PMS2-GFP-N; 18: MLH1-Red-C/PMS2-GFP-C. Symbols see Figure 1.
doi:10.1371/journal.pone.0031863.g004
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N1- or pDSRed-N1-MLH1 (MLH1-GFP-C or MLH1-Red-C)
and pECFP-N1- or pDSRed-N1-PMS2 (PMS2-GFP-C or PMS2-
Red-C) were generated by subcloning of wild-type MLH1 [22] or
PMS2 [22] using EcoRI and KpnI (DNA-cloning, Hamburg,
Germany) into pECFP-N1 or pDSRed-N1 (Clontech Lab., Palo
Alto, CA, USA). All used dye labeled MMR proteins are
illustrated in Figure 1, confirmed by sequencing and reading
frames were corrected using site-directed mutagenesis, if necessary.
Oligonucleotides were purchased from Sigma-Aldrich (Munich,
Germany).
Antibodies, Western blot analysis, and protein
quantification
Anti-MLH1 (G168-728) was obtained from Pharmingen (BD
Biosciences, United States), anti-PMS2 (E-19) was from Santa
Cruz Biotechnology (Santa Cruz, CA), and anti-b-Actin (Clone
AC-15) was purchased from Sigma (Sigma-Aldrich, Munich,
Germany). FITC-labeled goat anti-mouse IgG Alexa Fluor 488 as
well as FITC-labeled goat anti-rabbit IgG Alexa Fluor 555 were
obtained from Invitrogen (Darmstadt, Germany).
Proteins were separated on 10% polyacrylamide gels, followed
by Western blotting on nitrocellulose membranes and antibody
detection using standard procedures.
The band intensity of proteins was quantified using Multi
Gauge V3.2 program (Fujifilm, Tokyo, Japan).
All experiments were performed in quadruplicate.
Confocal Laser Microscopy
To analyze the influence of fluorescent labeling on cellular
localization of MLH1 or PMS2 proteins, HEK293T cells were
transiently transfected with unlabeled, GFP- or Red-labeled
variants. Briefly, HEK293T cells were spread on coverslipes to
50% confluence 4 h prior transfection and transfected with
expression plasmids (1 mg/ml, respectively) using 10 ml/ml of the
cationic polymer polyethylenimine (Polysciences, Warrington, PA;
stock solution 1 mg/ml). After 48 h, cells were prepared for
confocal laser scanning microscopy essentially as described
previously [10]. In brief, all cells transfected with fluorescent
labeled as well as those transfected with unlabeled proteins were
washed twice with PBS, fixed for 10 min in 3% formaldehyde in
PBS, followed by permeabilization with 0.1% Triton X-100 for
5 min. Furthermore, cells transfected with unlabeled MLH1 or
PMS2 were incubated for 1 h with the primary antibodies against
MLH1 (1:1000) or PMS2 (1:1000) at room temperature,
respectively. MLH1 antibody binding was detected with a
FITC-labeled goat anti-rabbit IgG Alexa Fluor 488 (1:1000)
whereas PMS2 antibody binding was detected with FITC labeled
Figure 5. Putative three-dimensional structure models of fluorescent labeled MutLa. Using PyMol (Warren DeLano, http://www.pymol.org/),
GFPor Red fluorescent proteinswere attachedto (A)N-terminiof MLH1 andPMS2 or (B)C-terminiofMutLa. C-terminal tags seem to hide theC-terminal
region of MutLa and consequently might avoid DNA interaction. (C) Corresponding amino acid sequences of linker regions are shown. The dashed line
between PMS2 and the N-terminal fluorescent tag illustrates a putative a-helix (unknown structure) of the first thirty amino acids of PMS2.
doi:10.1371/journal.pone.0031863.g005
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3 (Invitrogen, Germany) diluted 1:1000 in PBS was added to all
coverslipes for 1 h at room temperature to counterstain nucleic
acids and coverslipes were washed again with PBS.
After that, samples were mounted with ProLong Gold
(Invitrogen, Germany) and examined using a Leica TCS-NT
confocal microscope (Leica Lasertechnik GmbH, Heidelberg,
Germany). Control for subcellular localization was carried out
using unlabeled MutLa and mock control for fluorescent labeled
MutLa was determined with the pECFP-C1/-N1- and pDSRed-
C1/-N1- vectors.
MMR Assay
To analyze the consequences of GFP or Red labeling different
MutLa variants were tested in vitro for MMR ability as described
before [23]. Briefly, 50 mg of HEK293T nuclear extract, which is
deficient in mismatch repair [21] was supplemented with 5 mg
whole protein extract from HEK293T cells expressing recombi-
nant MutLa constructs. A substrate plasmid bearing a G-T
mismatch within an EcoRV restriction site was added to these
protein compositions, which is restored when repair occurs
directed by a 39 single-strand nick at a distance of 83 bp to the
mismatch. Reactions were incubated at 37uC for 20 min and
terminated with 50 ml stop-buffer (24 mM EDTA pH 8.0, 0.7%
SDS, 2 mg/ml proteinase K) by an additional incubation for
15 min at 37uC. Plasmids were extracted from the reaction
mixture by phenol-chloroform extraction and purified by ethanol
co-precipitation with tRNA. Subsequent digestion with EcoRV as
well as AseI produced two smaller fragments besides the linearized
vector (which is generated by AseI digestion) when repair was
successful. Restriction digests were separated on 2% agarose gels,
stained with ethidium bromide and bands were quantified using
Quantity One Software v4.6.1 (Bio-Rad, Hercules, CA, USA).
Repair efficiency of unlabeled MutLa was set at 100 percent and
repair of fluorescent tagged MutLa was determined in relation to
the wild-type sample that was expressed, processed and tested in
parallel.
Although the amount of mismatched plasmid DNA present in
parallel incubations is always identical (aliquoted from one master
mix), phenol-extraction/ethanol precipitation of the processed
plasmid can show differences in recovery, and therefore the overall
DNA amounts can differ from lane to lane. However, repair
efficiency is measured as quotient of the intensities of bands
indicating repair and the sum of all band intensities and therefore
gives an accurate repair value independent of the amount of DNA
actually recovered during plasmid extraction.
All experiments were performed in quadruplicate.
Structural modeling of fluorescent labeled MutLa
Structural modeling of MutLa as well as three-dimensional
structures of GFP- or Red-proteins has been described previously
[24,25,26,27]. Protein structures were visualized using PyMol
(Warren DeLano, http://www.pymol.org/).
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